{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T17:27:28Z","timestamp":1780939648361,"version":"3.54.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,1,9]],"date-time":"2014-01-09T00:00:00Z","timestamp":1389225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s40618-013-0032-y","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T11:16:48Z","timestamp":1389179808000},"page":"181-187","source":"Crossref","is-referenced-by-count":18,"title":["Serum galectin-3 levels in women with PCOS"],"prefix":"10.1007","volume":"37","author":[{"given":"H.","family":"Yilmaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. T.","family":"Celik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Ozdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Kalkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Namuslu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Abusoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. R.","family":"Atalay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Yigitoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,1,9]]},"reference":[{"issue":"3","key":"32_CR1","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/MED.0b013e32832afd4d","volume":"16","author":"V Nisenblat","year":"2009","unstructured":"Nisenblat V, Norman RJ (2009) Androgens and polycystic ovary syndrome. Curr Opin Endocrinol Diabetes Obes 16(3):224\u2013231","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"1","key":"32_CR2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3949\/ccjm.70.1.31","volume":"70","author":"TL Marx","year":"2003","unstructured":"Marx TL, Mehta AE (2003) Polycystic ovary syndrome: pathogenesis and treatment over the short and long term. Cleve Clin J Med 70(1):31\u201341","journal-title":"Cleve Clin J Med"},{"key":"32_CR3","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(07)61345-2","volume":"370","author":"RJ Norman","year":"2007","unstructured":"Norman RJ, Dewailly D, Legro RS, Hickey TE (2007) Polycystic ovary syndrome. Lancet 370:685\u2013697","journal-title":"Lancet"},{"key":"32_CR4","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1161\/01.ATV.15.7.821","volume":"15","author":"E Talbott","year":"1995","unstructured":"Talbott E, Guzick D, Clerici A et al (1995) Coronary heart disease risk factors in women with polycystic ovary syndrome. Arterioscler Thromb Vasc Biol 15:821\u2013826","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"32_CR5","doi-asserted-by":"crossref","first-page":"27S","DOI":"10.1016\/S0002-9343(99)80056-4","volume":"98","author":"RA Wild","year":"1995","unstructured":"Wild RA (1995) Obesity, lipids, cardiovascular risk, and androgen excess. Am J Med 98:27S\u201332S","journal-title":"Am J Med"},{"issue":"1","key":"32_CR6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.fertnstert.2011.11.023","volume":"97","author":"AJ Duleba","year":"2012","unstructured":"Duleba AJ, Dokras A (2012) Is PCOS an inflammatory process? Fertil Steril 97(1):7\u201312","journal-title":"Fertil Steril"},{"issue":"2","key":"32_CR7","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ejogrb.2013.01.015","volume":"168","author":"HO El-Mesallamy","year":"2013","unstructured":"El-Mesallamy HO, Abd El-Razek RS, El-Refaie TA (2013) Circulating high-sensitivity C-reactive protein and soluble CD40 ligand are inter-related in a cohort of women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 168(2):178\u2013182","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"32_CR8","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.mce.2010.08.002","volume":"335","author":"A Repaci","year":"2011","unstructured":"Repaci A, Gambineri A, Pasquali R (2011) The role of low-grade inflammation in the polycystic ovary syndrome. Mol Cell Endocrinol 335(1):30\u201341","journal-title":"Mol Cell Endocrinol"},{"key":"32_CR9","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2337\/diacare.22.1.141","volume":"22","author":"DA Ehrmann","year":"1999","unstructured":"Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghan MK, Imperial J (1999) Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 22:141\u2013146","journal-title":"Diabetes Care"},{"issue":"1","key":"32_CR10","first-page":"31","volume":"33","author":"MF Azevedo","year":"2011","unstructured":"Azevedo MF, Costa EC, Oliveira AIN, Silva IBO, Marinho JCDB, Rodrigues JAM et al (2011) Elevated blood pressure in women with polycystic ovary syndrome: prevalence and associated risk factors. Rev Bras Ginecol Obstet 33(1):31\u201336","journal-title":"Rev Bras Ginecol Obstet"},{"key":"32_CR11","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1210\/jcem.87.2.8199","volume":"87","author":"CJ Kelly","year":"2002","unstructured":"Kelly CJ, Speirs A, Gould GW et al (2002) Altered vascular function in young women with polycystic ovary syndrome. J Clin Endocrinol Metab 87:742\u2013746","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"32_CR12","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1600-065X.2009.00794.x","volume":"230","author":"NC Henderson","year":"2009","unstructured":"Henderson NC, Sethi T (2009) The regulation of inflammation by galectin-3. Immunol Rev 230(1):160\u2013171","journal-title":"Immunol Rev"},{"issue":"14","key":"32_CR13","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jacc.2012.04.053","volume":"60","author":"JE Ho","year":"2012","unstructured":"Ho JE, Liu C, Lyass A, Courchesne P, Pencina MJ, Vasan RS, Larson MG, Levy D (2012) Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community. J Am Coll Cardiol 60(14):1249\u20131256","journal-title":"J Am Coll Cardiol"},{"key":"32_CR14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1365-2796.2011.02476.x","volume":"272","author":"RA Boer de","year":"2012","unstructured":"de Boer RA, van Veldhuisen DJ, Gansevoort RT et al (2012) The fibrosis marker galectin-3 and outcome in the general population. J Intern Med 272:55\u201364","journal-title":"J Intern Med"},{"key":"32_CR15","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.brainres.2009.06.073","volume":"1288","author":"Y Yan","year":"2009","unstructured":"Yan Y, Lang B, Vemuganti R et al (2009) Galectin-3 mediates post-ischemic tissue remodeling. Brain Res 1288:116\u2013124","journal-title":"Brain Res"},{"key":"32_CR16","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0014-5793(98)00683-8","volume":"430","author":"C Arar","year":"1998","unstructured":"Arar C, Gaudin JC, Capron L, Legrand A (1998) Galectin-3 gene (LGALS3) expression in experimental atherosclerosis and cultured smooth muscle cells. FEBS Lett 430:307\u2013311","journal-title":"FEBS Lett"},{"issue":"4","key":"32_CR17","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1177\/039463201102400409","volume":"24","author":"C Falcone","year":"2011","unstructured":"Falcone C, Lucibello S, Mazzucchelli I, Bozzini S, D\u2019Angelo A, Schirinzi S, Totaro R, Falcone R, Bondesan M, Pelissero G (2011) Galectin-3 plasma levels and coronary artery disease: a new possible biomarker of acute coronary syndrome. Int J Immunopathol Pharmacol 24(4):905\u2013913","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"1","key":"32_CR18","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2353\/ajpath.2008.070348","volume":"172","author":"M Nachtigal","year":"2008","unstructured":"Nachtigal M, Ghaffar A, Mayer EP (2008) Galectin-3 gene inactivation reduces atherosclerotic lesions and adventitial inflammation in ApoE-deficient mice. Am J Pathol 172(1):247\u2013255","journal-title":"Am J Pathol"},{"issue":"1","key":"32_CR19","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.clim.2008.08.024","volume":"130","author":"EP Mensah-Brown","year":"2009","unstructured":"Mensah-Brown EP (2009) Al Rabesi Z, Shahin A, Al Shamsi M, Arsenijevic N, Hsu DK, Liu FT, Lukic ML. Targeted disruption of the galectin-3 gene results in decreased susceptibility to multiple low dose streptozotocin-induced diabetes in mice. Clin Immunol 130(1):83\u201388","journal-title":"Clin Immunol"},{"issue":"3","key":"32_CR20","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1210\/jc.2009-1619","volume":"95","author":"J Weigert","year":"2010","unstructured":"Weigert J, Neumeier M, Wanninger J, Bauer S, Farkas S, Scherer MN, Schnitzbauer A, Sch\u00e4ffler A, Aslanidis C, Sch\u00f6lmerich J, Buechler C (2010) Serum galectin-3 is elevated in obesity and negatively correlates with glycosylated hemoglobin in type 2 diabetes. J Clin Endocrinol Metab 95(3):1404\u20131411","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"32_CR21","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.2337\/db12-0222","volume":"62","author":"NN Pejnovic","year":"2013","unstructured":"Pejnovic NN, Pantic JM, Jovanovic IP, Radosavljevic GD, Milovanovic MZ, Nikolic IG, Zdravkovic NS, Djukic AL, Arsenijevic NN, Lukic ML (2013) Galectin-3 deficiency accelerates high-fat diet-induced obesity and amplifies inflammation in adipose tissue and pancreatic islets. Diabetes 62(6):1932\u20131944","journal-title":"Diabetes"},{"issue":"5","key":"32_CR22","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1369\/jhc.6A7053.2007","volume":"55","author":"J Nio","year":"2007","unstructured":"Nio J, Iwanaga T (2007) Galectins in the mouse ovary: concomitant expression of galectin-3 and progesterone degradation enzyme (20alpha-HSD) in the corpus luteum. J Histochem Cytochem 55(5):423\u2013432","journal-title":"J Histochem Cytochem"},{"key":"32_CR23","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.cellbi.2006.11.036","volume":"31","author":"H Kim","year":"2007","unstructured":"Kim H, Lee J, Hyun JW, Park JW, Joo HG, Shin T (2007) Expression and immunohistochemical localization of galectin-3 invarious mouse tissues. Cell Biol Int 31:655\u2013662","journal-title":"Cell Biol Int"},{"issue":"6","key":"32_CR24","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.acthis.2008.02.004","volume":"110","author":"M Kim","year":"2008","unstructured":"Kim M, Kim S, Kim H, Kim H, Joo HG, Shin T (2008) Immunohistochemical localization of galectin-3 in the reproductive organs of the cow. Acta Histochem 110(6):473\u2013480","journal-title":"Acta Histochem"},{"issue":"4","key":"32_CR25","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s12029-010-9189-1","volume":"42","author":"L Zaia Povegliano","year":"2011","unstructured":"Zaia Povegliano L, Oshima CT, de Oliveira Lima F, Andrade Scherholz PL, Manoukian Forones N (2011) Immunoexpression of galectin-3 in colorectal cancer and its relationship with survival. J Gastrointest Cancer 42(4):217\u2013221","journal-title":"J Gastrointest Cancer"},{"issue":"5","key":"32_CR26","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.2353\/ajpath.2010.090353","volume":"176","author":"CG Chiu","year":"2010","unstructured":"Chiu CG, Strugnell SS, Griffith OL, Jones SJ, Gown AM, Walker B, Nabi IR, Wiseman SM (2010) Diagnostic utility of galectin-3 in thyroid cancer. Am J Pathol 176(5):2067\u20132081","journal-title":"Am J Pathol"},{"key":"32_CR27","first-page":"1307","volume":"9","author":"J Miyazaki","year":"2002","unstructured":"Miyazaki J, Hokari R, Kato S, Tsuzuki Y, Kawaguchi A, Nagao S, Itoh K, Miura S (2002) Increased expression of galectin-3 in primary gastric cancer and the metastatic lymph nodes. Oncol Rep 9:1307\u20131312","journal-title":"Oncol Rep"},{"key":"32_CR28","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/hed.20559","volume":"9","author":"S Saussez","year":"2007","unstructured":"Saussez S, Camby I, Toubeau G, Kiss R (2007) Galectins as modulators of tumor progression in head and neck squamous cell carcinomas. Head Neck 9:874\u2013884","journal-title":"Head Neck"},{"issue":"2","key":"32_CR29","doi-asserted-by":"crossref","first-page":"e57915","DOI":"10.1371\/journal.pone.0057915","volume":"8","author":"J Pang","year":"2013","unstructured":"Pang J, Rhodes DH, Pini M, Akasheh RT, Castellanos KJ, Cabay RJ, Cooper D, Perretti M, Fantuzzi G (2013) Increased adiposity, dysregulated glucose metabolism and systemic inflammation in galectin-3 KO mice. PLoS One 8(2):e57915","journal-title":"PLoS One"},{"issue":"1","key":"32_CR30","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-2265.2004.02170.x","volume":"62","author":"E Diamanti-Kandarakis","year":"2005","unstructured":"Diamanti-Kandarakis E, Piperi C, Kalofoutis A, Creatsas G (2005) Increased levels of serum advanced glycation end-products in women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 62(1):37\u201343","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"32_CR31","doi-asserted-by":"crossref","first-page":"292","DOI":"10.14310\/horm.2002.1320","volume":"10","author":"C Christakou","year":"2011","unstructured":"Christakou C, Economou F, Livadas S, Piperi C, Adamopoulos C, Marinakis E, Jdiamanti-Kandarakis E (2011) Strong and positive association of endothelin-1 with AGEs in PCOS: a causal relationship or a bystander? Hormones (Athens) 10(4):292\u2013297","journal-title":"Hormones (Athens)"},{"key":"32_CR32","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1096\/fj.04-2031fje","volume":"18","author":"C Iacobini","year":"2004","unstructured":"Iacobini C, Menini S, Oddi G, Ricci C, Amadio L, Pricci F, Olivieri A, Sorcini M, Di Mario U, Pesce C, Pugliese G (2004) Galectin-3\/AGE-receptor 3 knockout mice show accelerated AGE-induced glomerular injury: evidence for a protective role of galectin-3 as an AGE receptor. FASEB J 18:1773\u20131775","journal-title":"FASEB J"},{"issue":"4","key":"32_CR33","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s10147-011-0190-x","volume":"16","author":"MK Kim","year":"2011","unstructured":"Kim MK, Sung CO, Do IG, Jeon HK, Song TJ, Park HS, Lee YY, Kim BG, Lee JW, Bae DS (2011) Overexpression of galectin-3 and its clinical significance in ovarian carcinoma. Int J Clin Oncol 16(4):352\u2013358","journal-title":"Int J Clin Oncol"},{"key":"32_CR34","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1530\/ror.0.0010162","volume":"1","author":"JL Tilly","year":"1996","unstructured":"Tilly JL (1996) Apoptosis and ovarian function. Rev Reprod 1:162\u2013172","journal-title":"Rev Reprod"},{"issue":"2","key":"32_CR35","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s10495-005-0801-y","volume":"10","author":"S Nakahara","year":"2005","unstructured":"Nakahara S, Oka N, Raz A (2005) On the role of galectin-3 in cancer apoptosis. Apoptosis 10(2):267\u2013275","journal-title":"Apoptosis"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-013-0032-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40618-013-0032-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-013-0032-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T00:22:00Z","timestamp":1565050920000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40618-013-0032-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,9]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["32"],"URL":"https:\/\/doi.org\/10.1007\/s40618-013-0032-y","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,9]]}}}